AC
Asio Capital’s Elevance Health ELV Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $5.98M | Buy |
15,371
+1,015
| +7% | +$395K | 1% | 29 |
|
2025
Q1 | $6.24M | Buy |
14,356
+3,446
| +32% | +$1.5M | 1.21% | 23 |
|
2024
Q4 | $4.02M | Buy |
10,910
+1,221
| +13% | +$450K | 0.76% | 44 |
|
2024
Q3 | $5.04M | Buy |
9,689
+229
| +2% | +$119K | 0.96% | 35 |
|
2024
Q2 | $5.13M | Buy |
9,460
+143
| +2% | +$77.5K | 1.05% | 31 |
|
2024
Q1 | $4.83M | Buy |
9,317
+162
| +2% | +$84K | 1.03% | 37 |
|
2023
Q4 | $4.32M | Buy |
9,155
+785
| +9% | +$370K | 1.01% | 35 |
|
2023
Q3 | $3.64M | Buy |
8,370
+813
| +11% | +$354K | 0.97% | 38 |
|
2023
Q2 | $3.36M | Buy |
7,557
+720
| +11% | +$320K | 0.82% | 47 |
|
2023
Q1 | $3.14M | Sell |
6,837
-2,709
| -28% | -$1.25M | 0.82% | 51 |
|
2022
Q4 | $4.9M | Hold |
9,546
| – | – | 1.41% | 18 |
|
2022
Q3 | $4.34M | Buy |
9,546
+226
| +2% | +$103K | 1.38% | 16 |
|
2022
Q2 | $4.5M | Buy |
9,320
+295
| +3% | +$142K | 1.42% | 14 |
|
2022
Q1 | $4.43M | Buy |
9,025
+598
| +7% | +$294K | 1.25% | 22 |
|
2021
Q4 | $3.91M | Buy |
8,427
+480
| +6% | +$222K | 1.22% | 28 |
|
2021
Q3 | $2.96M | Buy |
7,947
+435
| +6% | +$162K | 1.02% | 42 |
|
2021
Q2 | $2.87M | Buy |
7,512
+277
| +4% | +$106K | 1.01% | 44 |
|
2021
Q1 | $2.6M | Buy |
7,235
+5,010
| +225% | +$1.8M | 1.07% | 42 |
|
2020
Q4 | $714K | Buy |
2,225
+80
| +4% | +$25.7K | 0.34% | 65 |
|
2020
Q3 | $576K | Buy |
2,145
+1,299
| +154% | +$349K | 0.32% | 64 |
|
2020
Q2 | $222K | Buy |
+846
| New | +$222K | 0.14% | 71 |
|